These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 34202794)

  • 21. Mesoporous silica materials: From physico-chemical properties to enhanced dissolution of poorly water-soluble drugs.
    Maleki A; Kettiger H; Schoubben A; Rosenholm JM; Ambrogi V; Hamidi M
    J Control Release; 2017 Sep; 262():329-347. PubMed ID: 28778479
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Progress in Mesoporous Silica Nanoparticles as Drug Delivery Agents for Cancer Treatment.
    Mohamed Isa ED; Ahmad H; Abdul Rahman MB; Gill MR
    Pharmaceutics; 2021 Jan; 13(2):. PubMed ID: 33498885
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparison of mesoporous silica nanoparticles and mesoporous organosilica nanoparticles as drug vehicles for cancer therapy.
    Yue J; Luo SZ; Lu MM; Shao D; Wang Z; Dong WF
    Chem Biol Drug Des; 2018 Aug; 92(2):1435-1444. PubMed ID: 29671941
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mesoporous Silica Nanoparticles for Protein Protection and Delivery.
    Xu C; Lei C; Yu C
    Front Chem; 2019; 7():290. PubMed ID: 31119124
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mesoporous Silica Nanoparticles: A Versatile Platform for Biomedical Applications.
    Jain P; Hassan N; Iqbal Z; Dilnawaz F
    Recent Pat Drug Deliv Formul; 2018; 12(4):228-237. PubMed ID: 30501606
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Review of Mesoporous Silica Nanoparticle Delivery Systems in Chemo-Based Combination Cancer Therapies.
    Gao Y; Gao D; Shen J; Wang Q
    Front Chem; 2020; 8():598722. PubMed ID: 33330389
    [TBL] [Abstract][Full Text] [Related]  

  • 27. How Can Doxorubicin Loading Orchestrate in Vitro Degradation Behaviors of Mesoporous Silica Nanoparticles under a Physiological Condition?
    Choi E; Kim S
    Langmuir; 2017 May; 33(20):4974-4980. PubMed ID: 28478674
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dual response to pH and chiral microenvironments for the release of a flurbiprofen-loaded chiral self-assembled mesoporous silica drug delivery system.
    Wu L; Gou K; Guo X; Guo Y; Chen M; Hou J; Li S; Li H
    Colloids Surf B Biointerfaces; 2021 Mar; 199():111501. PubMed ID: 33338882
    [TBL] [Abstract][Full Text] [Related]  

  • 29. pH-responsive nanoreservoirs based on hyaluronic acid end-capped mesoporous silica nanoparticles for targeted drug delivery.
    Chen C; Sun W; Wang X; Wang Y; Wang P
    Int J Biol Macromol; 2018 May; 111():1106-1115. PubMed ID: 29357289
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Controlled release of silyl ether camptothecin from thiol-ene click chemistry-functionalized mesoporous silica nanoparticles.
    Yan Y; Fu J; Wang T; Lu X
    Acta Biomater; 2017 Mar; 51():471-478. PubMed ID: 28131940
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mesoporous silica nanoparticles for intracellular controlled drug delivery.
    Vivero-Escoto JL; Slowing II; Trewyn BG; Lin VS
    Small; 2010 Sep; 6(18):1952-67. PubMed ID: 20690133
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Near-infrared light triggered drug release from mesoporous silica nanoparticles.
    Zhao T; Chen L; Li Q; Li X
    J Mater Chem B; 2018 Nov; 6(44):7112-7121. PubMed ID: 32254627
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sugar-decorated mesoporous silica nanoparticles as delivery vehicles for the poorly soluble drug celastrol enables targeted induction of apoptosis in cancer cells.
    Niemelä E; Desai D; Nkizinkiko Y; Eriksson JE; Rosenholm JM
    Eur J Pharm Biopharm; 2015 Oct; 96():11-21. PubMed ID: 26184689
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mesoporous Silica-Based Nanoplatforms Are Theranostic Agents for the Treatment of Inflammatory Disorders.
    Sivamaruthi BS; Thangaleela S; Kesika P; Suganthy N; Chaiyasut C
    Pharmaceutics; 2023 Jan; 15(2):. PubMed ID: 36839761
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Advances in Peptide Functionalization on Mesoporous Silica Nanoparticles for Controlled Drug Release.
    Hu JJ; Xiao D; Zhang XZ
    Small; 2016 Jul; 12(25):3344-59. PubMed ID: 27152737
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Successfully tailoring the pore size of mesoporous silica nanoparticles: exploitation of delivery systems for poorly water-soluble drugs.
    Jia L; Shen J; Li Z; Zhang D; Zhang Q; Duan C; Liu G; Zheng D; Liu Y; Tian X
    Int J Pharm; 2012 Dec; 439(1-2):81-91. PubMed ID: 23078857
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phytochemical-loaded mesoporous silica nanoparticles for nose-to-brain olfactory drug delivery.
    Lungare S; Hallam K; Badhan RK
    Int J Pharm; 2016 Nov; 513(1-2):280-293. PubMed ID: 27633279
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multifunctional Mesoporous Silica Nanoparticles for Cancer Therapy and Imaging.
    Dilnawaz F
    Curr Med Chem; 2019; 26(31):5745-5763. PubMed ID: 29714137
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mesoporous silica nanoparticles carrying multiple antibiotics provide enhanced synergistic effect and improved biocompatibility.
    Gounani Z; Asadollahi MA; Pedersen JN; Lyngsø J; Skov Pedersen J; Arpanaei A; Meyer RL
    Colloids Surf B Biointerfaces; 2019 Mar; 175():498-508. PubMed ID: 30572158
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recent advances in mesoporous silica nanoparticles for antitumor therapy: our contribution.
    Baeza A; Manzano M; Colilla M; Vallet-Regí M
    Biomater Sci; 2016 May; 4(5):803-13. PubMed ID: 26902682
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.